Invesco Pharmaceuticals ETF
PJP
PJP
120 hedge funds and large institutions have $151M invested in Invesco Pharmaceuticals ETF in 2026 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 33 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
14% more funds holding
Funds holding: 105 → 120 (+15)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $259K
Holders
120
Holding in Top 10
–
Calls
–
Puts
$259K
Top Buyers
| 1 | +$24.4M | |
| 2 | +$23.4M | |
| 3 | +$5.51M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$5.45M |
| 5 |
CI
Cavalier Investments
Alpharetta,
Georgia
|
+$4.85M |
Top Sellers
| 1 | -$739K | |
| 2 | -$565K | |
| 3 | -$533K | |
| 4 |
GC
Grimes & Company
Westborough,
Massachusetts
|
-$502K |
| 5 |
BlackRock
New York
|
-$367K |
